LOGIN
OTA 2016: Assessing the efficacy & safety of TXA in arthroplasty for femoral neck fracture
October 2016
OTA 2016: Assessing the efficacy & safety of TXA in arthroplasty for femoral neck fracture
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tranexamic acid safely reduced blood loss in hip arthroplasty for acute femoral neck fracture
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
138 patients with a femoral neck fracture scheduled for total hip arthroplasty were randomized to be managed with either tranexamic acid or placebo. Calculated total blood loss, transfusion requirement, and adverse events/complications were assessed. The tranexamic acid group demonstrated a statistically significant 305mL reduction in total blood loss compared to the placebo group, though no signi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.